Resultados de búsqueda - Gil Redelman‐Sidi

  • Mostrando 1 - 13 Resultados de 13
Limitar resultados
  1. 1
    Could BCG be used to protect against COVID-19?

    Could BCG be used to protect against COVID-19? por Gil Redelman‐Sidi

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    BCG in Bladder Cancer Immunotherapy

    BCG in Bladder Cancer Immunotherapy por Song Jiang, Gil Redelman‐Sidi

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    Rapidly Growing Mycobacteria Infection in Patients with Cancer

    Rapidly Growing Mycobacteria Infection in Patients with Cancer por Gil Redelman‐Sidi, Kent A. Sepkowitz

    Publicado 2010
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy por Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington

    Publicado 2021
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  5. 5
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells por Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman

    Publicado 2013
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways

    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways por Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi, Stewart Shuman, Michael S. Glickman

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling

    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling por Anthony C. Antonelli, Anna Binyamin, Tobias M. Hohl, Michael S. Glickman, Gil Redelman‐Sidi

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... por Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  9. 9
    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer por Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma por María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer

    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer por Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Determinants of Severity in Cancer Patients with COVID-19 Illness

    Determinants of Severity in Cancer Patients with COVID-19 Illness por Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Publicado 2020
    Enlace del recurso
    Pré-impressão
    Agregar a favoritos
    Guardado en:
  13. 13
    Determinants of COVID-19 disease severity in patients with cancer

    Determinants of COVID-19 disease severity in patients with cancer por Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: